SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-08-015808
Filing Date
2008-03-17
Accepted
2008-03-17 16:07:12
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 v107109_10k.htm 10-K 2870092
2 GRAPHIC chart.jpg GRAPHIC 47593
3 v107109_ex21.htm EX-21 9184
4 v107109_ex23-1.htm EX-23.1 4406
5 v107109_ex23-2.htm EX-23.2 4301
6 v107109_ex31-1.htm EX-31.1 18859
7 v107109_ex31-2.htm EX-31.2 15791
8 v107109_ex32-1.htm EX-32.1 5965
9 v107109_ex32-2.htm EX-32.2 5835
  Complete submission text file 0001144204-08-015808.txt   3001601
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13441 | Film No.: 08693048
SIC: 2836 Biological Products, (No Diagnostic Substances)